P38 MAPK Signaling Pathway Mediates Angiotensin II-Induced miR143/145 Gene Cluster Downregulation during Aortic Dissection Formation
- 1 April 2017
- journal article
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 40, 262-273
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive SummaryCatheterization and Cardiovascular Interventions, 2010
- Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 2004
- Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: Morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitorsHuman Pathology, 2001
- Tissue Angiotensin and Pathobiology of Vascular DiseaseHypertension, 2001
- Essential role for p38α mitogen-activated protein kinase in placental angiogenesisProceedings of the National Academy of Sciences, 2000
- Requirement for p38α in Erythropoietin ExpressionCell, 2000
- Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient miceJournal of Clinical Investigation, 2000
- Central Role of the MAPK Pathway in Ang II–Mediated DNA Synthesis and Migration in Rat Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Regulation of the ERK Subgroup of MAP Kinase Cascades Through G Protein-Coupled ReceptorsCellular Signalling, 1997
- Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.Circulation Research, 1988